SummaryThe HIV-1 envelope (Env) spike contains limited epitopes for broadly neutralizing antibodies (bNAbs); thus, most neutralizing antibodies are strain specific. The 8ANC195 epitope, defined by crystal and electron microscopy (EM) structures of bNAb 8ANC195 complexed with monomeric gp120 and trimeric Env, respectively, spans the gp120 and gp41 Env subunits. To investigate 8ANC195’s gp41 epitope at higher resolution, we solved a 3.58 Å crystal structure of 8ANC195 complexed with fully glycosylated Env trimer, revealing 8ANC195 insertion into a glycan shield gap to contact gp120 and gp41 glycans and protein residues. To determine whether 8ANC195 recognizes the CD4-bound open Env conformation that leads to co-receptor binding and fusion, on...
HIV-1 broadly neutralizing antibodies are desired for their therapeutic potential and as templates f...
Acquired immunodeficiency syndrome (AIDS) and its causal agent, the human immunodeficiency virus 1 (...
Acquired immunodeficiency syndrome (AIDS) and its causal agent, the human immunodeficiency virus 1 (...
The HIV-1 envelope (Env) spike contains limited epitopes for broadly neutralizing antibodies (bNAbs)...
The HIV-1 envelope (Env) spike contains limited epitopes for broadly neutralizing antibodies (bNAbs)...
SummaryThe HIV-1 envelope (Env) spike contains limited epitopes for broadly neutralizing antibodies ...
The HIV-1 envelope (Env) spike contains limited epitopes for broadly neutralizing antibodies (bNAbs)...
The HIV-1 envelope (Env) spike contains limited epitopes for broadly neutralizing antibodies (bNAbs)...
SummaryBroadly neutralizing antibodies (bNAbs) to HIV-1 envelope glycoprotein (Env) can prevent infe...
Broadly neutralizing antibodies (bNAbs) to HIV-1 envelope glycoprotein (Env) can prevent infection i...
Broadly neutralizing antibodies (bNAbs) to HIV-1 envelope glycoprotein (Env) can prevent infection i...
Broadly neutralizing antibodies (bNAbs) to HIV-1 envelope glycoprotein (Env) can prevent infection i...
The identification of HIV-1 envelope glycoprotein (Env) structures that can generate broadly neutral...
The HIV-1 envelope (Env) glycoprotein binds to host cell receptors to mediate membrane fusion. The p...
The HIV-1 envelope (Env) glycoprotein binds to host cell receptors to mediate membrane fusion. The p...
HIV-1 broadly neutralizing antibodies are desired for their therapeutic potential and as templates f...
Acquired immunodeficiency syndrome (AIDS) and its causal agent, the human immunodeficiency virus 1 (...
Acquired immunodeficiency syndrome (AIDS) and its causal agent, the human immunodeficiency virus 1 (...
The HIV-1 envelope (Env) spike contains limited epitopes for broadly neutralizing antibodies (bNAbs)...
The HIV-1 envelope (Env) spike contains limited epitopes for broadly neutralizing antibodies (bNAbs)...
SummaryThe HIV-1 envelope (Env) spike contains limited epitopes for broadly neutralizing antibodies ...
The HIV-1 envelope (Env) spike contains limited epitopes for broadly neutralizing antibodies (bNAbs)...
The HIV-1 envelope (Env) spike contains limited epitopes for broadly neutralizing antibodies (bNAbs)...
SummaryBroadly neutralizing antibodies (bNAbs) to HIV-1 envelope glycoprotein (Env) can prevent infe...
Broadly neutralizing antibodies (bNAbs) to HIV-1 envelope glycoprotein (Env) can prevent infection i...
Broadly neutralizing antibodies (bNAbs) to HIV-1 envelope glycoprotein (Env) can prevent infection i...
Broadly neutralizing antibodies (bNAbs) to HIV-1 envelope glycoprotein (Env) can prevent infection i...
The identification of HIV-1 envelope glycoprotein (Env) structures that can generate broadly neutral...
The HIV-1 envelope (Env) glycoprotein binds to host cell receptors to mediate membrane fusion. The p...
The HIV-1 envelope (Env) glycoprotein binds to host cell receptors to mediate membrane fusion. The p...
HIV-1 broadly neutralizing antibodies are desired for their therapeutic potential and as templates f...
Acquired immunodeficiency syndrome (AIDS) and its causal agent, the human immunodeficiency virus 1 (...
Acquired immunodeficiency syndrome (AIDS) and its causal agent, the human immunodeficiency virus 1 (...